40% Savings in Low-Back Pain Related Healthcare Costs


Musculoskeletal (MSK) disorders are the #1 Global Burden causing reduced ability to work, absenteeism, reduced productivity, and increasing healthcare costs (direct and indirect). Every fifth visit to a doctor takes place because of the MSK problems.

In treating MSK disorders there is still an absence of scalable solutions and widely used current common practices are bedrest, painkillers and surgeries.

Small group of high risk patients consume the majority of healthcare expenses.


DBC offers a scalable comprehensive continuum of MSK prevention and care. Triage and evaluation for severity and cost-trajectory by risk category. DBC utilizes proven treatment solutions to conservatively address MSK problems in a time- and cost-effective manner; getting people back to work while eliminating costs associated with ineffective and unnecessary treatments. Outcome driven prevention and treatments are becoming standard practice and DBC's proven processes can lead the way in reducing escalation and resolving the problems with sustainable DBC solutions for root causes.


A significant portion of the costs associated with MSK problems result from unnecessary, improperly scheduled, or ineffective treatments. Insurance groups and employers require an effective long-term solution that will positively affect the majority of their clients and employees. DBC has a proven track record for high risk patients with strong documented treatment outcomes; cost effective treatment processes; long-term treatment results; and reduced absences from the workplace. With scalable application based triage DBC can now offer service pathways to the full continuum of care, including proactive training content for low risk, professional guidance, and treatment for medium risk as well as the services of DBC Center of Excellence for the high risk MSK customers.


“The DBC Concept has been used in South Africa since 1999 and it has provided substantial value in terms of reported successful medical outcomes to patients and sustained savings in healthcare costs associated with musculoskeletal care.”

Albert Van Zijl, GM, Klinikka (Pty) Ltd. - a subsidiary of Afrocentric Health Ltd.